ArticleCancers2026

15-Day Duration of Venetoclax Combined with Azacitidine in Treatment-Naive Higher-Risk Myelodysplastic Syndromes: A Prospective Multicenter Study.

Binbin Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.